Jie Xu

Also affiliated with Sichuan Agricultural University, Luye Pharma (China), Regend Therapeutics (China)

Biochemistry, Genetics and Molecular BiologyAgricultural and Biological SciencesVeterinary

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Engineering circular guide RNA and CRISPR-Cas13d-encoding mRNA for the RNA editing of Adar1 in triple-negative breast cancer immunotherapy”.

Engineering circular guide RNA and CRISPR-Cas13d-encoding mRNA for the RNA editing of Adar1 in triple-negative breast cancer immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.22.666181

N/A

0DataRank · unranked

1 citations

Suling Yang, Jie Xu, Guizhi Zhu, Shurong Zhou